Fund will support research organizations through competitive, peer-reviewed process OTTAWA, ON — The scientific breakthroughs of tomorrow will be born out of the work that our researchers and innovators are… Read More
ALA-002 is PharmAla’s lead drug candidate, showing exceptional safety and efficacy in preclinical rodent models VANCOUVER, BC — PharmAla Biotech (CSE:MDMA) is pleased to announce that it has submitted its… Read More
Bausch Health, Canada is pleased to announce that on August 29, 2022, it signed a letter of intent (LOI) with the Pan-Canadian Pharmaceutical Alliance (pCPA) for Arazlo (tazarotene) indicated for… Read More
VANCOUVER, BC — (BUSINESS WIRE) — AbCellera (Nasdaq: ABCL) announced today that Regeneron has elected to exercise its right to advance a therapeutic antibody candidate, discovered in partnership with AbCellera as… Read More
The Discovery Group has appointed Mathew Merritt as Director of Finance, Nimbus Synergies. Mathew will be taking over for Alfred Sequeira, who is retiring in early 2023. Mathew joins after… Read More
